STAT Plus: Up and down the ladder: The latest comings and goings
jobs
STAT Pharmalot columnist Ed Silverman follows the comings and goings of heavy hitters and major players in the life sciences, pharma and biotech industries. To see who’s landing the prime jobs, bookmark this page.
Latest
STAT Plus: Biopharma layoffs are leaving the industry’s scientists reeling — and in search of scarce opportunities
STAT Plus: Up and down the ladder: The latest comings and goings
STAT Plus: Up and down the ladder: The latest comings and goings
STAT Plus: Up and down the ladder: The latest comings and goings
STAT Plus: Up and down the ladder: The latest comings and goings
STAT Plus: RNA startup ReNAgade cuts staff seven months after raising $300 million
STAT Plus: Up and down the ladder: The latest comings and goings
All Coverage
advertisement